Stock 0LSZ WALGREENS BOOTS ALLIANCE, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Walgreens Boots Alliance, Inc. London S.E.

Equities

0LSZ

US9314271084

Real-time Estimate Cboe BZX
Other stock markets
 10:47:40 2024-07-03 EDT 		5-day change 1st Jan Change
11.28 USD -6.04% Intraday chart for Walgreens Boots Alliance, Inc. -23.80% -53.81%
04:19pm UBS Adjusts Price Target on Walgreens Boots Alliance to $12 From $17, Maintains Neutral Rating MT
07-02 Sector Update: Health Care Stocks Softer Late Afternoon MT

Strengths

  • The company shows low valuation levels, with an enterprise value at 0.12 times its sales.
  • The company appears to be poorly valued given its net asset value.
  • Given the positive cash flows generated by its business, the company's valuation level is an asset.
  • This company will be of major interest to investors in search of a high dividend stock.
  • The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.

Weaknesses

  • With relatively low growth outlooks, the group is not among those with the highest revenue growth potential.
  • The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
  • Low profitability weakens the company.
  • For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
  • For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
  • Over the past four months, analysts' average price target has been revised downwards significantly.
  • Over the past twelve months, analysts' opinions have been revised negatively.
  • Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
  • The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.

Ratings chart - Surperformance

Sector: Drug Retailers

1st Jan change Capi. Investor Rating ESG Refinitiv
WALGREENS BOOTS ALLIANCE, INC. Stock Walgreens Boots Alliance, Inc.
-53.81% 9.99B -
JD HEALTH INTERNATIONAL INC. Stock JD Health International Inc.
-44.76% 8.55B
B
ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED Stock Alibaba Health Information Technology Limited
-24.53% 6.38B
B
MATSUKIYOCOCOKARA & CO. Stock MatsukiyoCocokara & Co.
-6.21% 6.06B
C+
CORPORATIVO FRAGUA, S.A.B. DE C.V. Stock Corporativo Fragua, S.A.B. de C.V.
+87.87% 4.97B
C
NAHDI MEDICAL COMPANY Stock Nahdi Medical Company
-3.36% 4.55B
D-
CLICKS GROUP LIMITED Stock Clicks Group Limited
+3.33% 4.3B
B
YIFENG PHARMACY CHAIN CO., LTD. Stock Yifeng Pharmacy Chain Co., Ltd.
-25.10% 4.17B
C
WELCIA HOLDINGS CO., LTD. Stock Welcia Holdings Co., Ltd.
-19.83% 2.53B
C-
SAUDI CHEMICAL HOLDING COMPANY Stock Saudi Chemical Holding Company
+154.63% 2.44B - -
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
-
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
-
EV / Sales
Price to Book
Price to Free Cash Flow
Yield

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. WBA Stock
  4. 0LSZ Stock
  5. Ratings Walgreens Boots Alliance, Inc.